induces an increase in growth hormone synthesis and messenger RNA in cultured GH1 cells, a rat pituitary cell line. In addition to regulating the growth hormone response, L-T3 elicits a time-and dose-dependent reduction in the level of its nuclear receptor, which is a direct function of the occupancy of the receptor binding site. In this study we have compared the relative affinity of L-T3, triiodothyroacetic acid, D-triiodothyronine (D-T3), and L-thyroxine (L-T4) for the receptor with the induction ofthe growth hormone synthesis and the ability of these compounds to elicit a reduction in thyroid hormone nuclear receptor levels. Triiodothyroacetic acid and D-T3 were specifically examined because the biologic effect of these compounds in the intact rat is significantly lower than predicted by their affinity for the receptor using isolated rat liver nuclei in vitro. In intact cells each compound demonstrated an excellent relationship between the relative receptor affinity, the induction of growth hormone production, and the concentration-dependent reduction in nuclear receptor levels. With the exception of D-T3, the relative affinity of iodothyronine was identical for the receptor using intact cells in serum-free media, or isolated GH, cell nuclei in vitro. The apparent receptor affinity of D-T3 with intact cells was 5.5-fold lower than with isolated nuclei, which suggests a decrease in cell entry of D-T3 relative 
A B S T R A C T We have previously demonstrated that L-triiodothyronine (L-T3) induces an increase in growth
hormone synthesis and messenger RNA in cultured GH1 cells, a rat pituitary cell line. In addition to regulating the growth hormone response, L-T3 elicits a time-and dose-dependent reduction in the level of its nuclear receptor, which is a direct function of the occupancy of the receptor binding site. In this study we have compared the relative affinity of L-T3, triiodothyroacetic acid, D-triiodothyronine (D-T3), and L-thyroxine (L-T4) for the receptor with the induction ofthe growth hormone synthesis and the ability of these compounds to elicit a reduction in thyroid hormone nuclear receptor levels. Triiodothyroacetic acid and D-T3 were specifically examined because the biologic effect of these compounds in the intact rat is significantly lower than predicted by their affinity for the receptor using isolated rat liver nuclei in vitro. In intact cells each compound demonstrated an excellent relationship between the relative receptor affinity, the induction of growth hormone production, and the concentration-dependent reduction in nuclear receptor levels. With the exception of D-T3, the relative affinity of iodothyronine was identical for the receptor using intact cells in serum-free media, or isolated GH, cell nuclei in vitro. The apparent receptor affinity of D-T3 with intact cells was 5.5-fold lower than with isolated nuclei, which suggests a decrease in cell entry of D-T3 relative to the other iodothyronines. Quantitation of the [1251] iodothyronine associated with the receptor in
INTRODUCTION
We have previously documented that GHl cells, a growth hormone-producing rat pituitary cell line, is a valid culture system which can be used to define the molecular action of physiological concentrations of thyroid hormone in mammalian cells (1) (2) (3) (4) (5) (6) (7) (8) . In this system, L-triiodothyronine (L-T3)1 stimulates a 3-to 10-fold increase in the rate of growth hormone synthesis (2, 5, 7) which is paralleled by changes in total cytoplasmic growth hormone imessenger RNA (mRNA) levels (8) . The physiological relevence of this effect in GH1 cells is underscored by the observation that thyroid hormone plays an important role in controlling the production of growth hormone in the rat pituitary in vivo (9) (10) (11) (12) , although thyroid growth hormone has been reported to have an equivocal effect on growth hormone production in dispersed anterior pituitary cells in vitro (13) .
The induction of growth hormone synthesis and mRNA in GH, cells appears to be mediated by the thyroid hormone nuclear receptor. This is based on the good agreement between the concentration-dependent occupancy of the receptor by L-T3 and the induction of the growth hormone response (6, 7) . In addition to inducing the growth hormone response, we have demonstrated that L-T3 elicits a time-and dose-dependent reduction of the thyroid hormone receptor to approximately one-halfofthe initial value (6, 7) . This hormonemediated receptor regulation appears to require the association of L-T3 with the receptor binding site (7) , and the decrease in nuclear receptor levels is associated with a decrease in the induced biological response (7) .
In addition to the GH, cell studies, a wide body of evidence indicates that the high affinity nuclear binding protein for L-T3 and L-thyroxine (L-T4) functions as a biologically relevant cellular receptor. This is based primarily on the good agreement between the relative affinity of thyroid hormone analogues for isolated liver nuclei in vitro and their reported in vivo biologic effects in terms of anti-goiter activity and 02 consumption (14) (15) (16) (17) (18) (19) , and induction of a-glycerophosphate dehydrogenase in rat liver (20) . Two hormonal analogues which show a higher affinity for the receptor, using isolated nuclei in vitro (21) (22) (23) ) as compared with their in vivo biological activity, are triiodothyroacetic acid (triac) and D-triiodothyronine (D-T3). It has been argued that this discrepancy indicates that the cell nucleus is not the only site of action of thyroid hormone in the cell (24) . Goslings et al. (25) Oxnard, Calif.) was carried out as previously described (1) (2) (3) (4) (5) (6) (7) (8) .
The cells were inoculated at initial cell densities between 2 and 4 x 104 cells/cm2 with growth medium (Ham's F-10 medium which contained 2.5% fetal calf serum and 15% horse serum) and were incubated at 37°C in an atmosphere of 95% air and 5% CO2 for 48-72 h. The medium was replaced with
Ham's F-10 medium which contained 10% hypothyroid calf serum, and the cells were incubated for an additional 24-48 h. This insured complete cellular depletion of thyroid hormone, which resulted from the growth of the cells with medium that contained euthyroid fetal calf and horse serum (4, 26 (5) (6) (7) (8) . After removing the medium, the cells were rinsed three times with 0.14 M NaCl at 4°C, and the cells were saved for quantitation of cell protein (28) or intracellular growth hormone by radioimmunoassay (2, 8) .
Rat anterior pituitary cell culture. Rat pituitaries were obtained from 200-g male Sprague-Dawley rats, dispersed as described by Vale et al. (29) , and inoculated into 2-cm2 multiwell plates at an initial cell density of 2-4 x 104 cells/cm2 as described for GH, cells. The influence of L-T3 on growth hormone production was determined with the protocol described above for GH, cells. This was determined by radioimmunoassay as well as by a 15-min incubation with L-[35S]-methionine followed by selective immunoprecipitation of the intracellular radiolabeled growth hormone as described for GH, cells (5) .
Quantitation of the relative affinity of hormonal analogues for the thyroid hormone nuclear receptor in GH1 cells and isolated nuclei. The protocol for cell inoculation and for exchange of medium that contained hypothyroid calf serum was exactly as described above with the studies on growth hormone production rates. Hormone binding studies with serum-supplemented medium were carried out under identical conditions as the biologic response was examined. An assessment of the relative affinity of L-T3, triac, D-T3, and L-T4 for the nuclear receptor was determined by incubating 
This formulation can be extended (Eq. 2) to estimate total nuclear receptor levels using iodothyronines other then L-T3, i.e., triac, D-T3, and L-T4, if the affinity of these compounds relative to L-T3 is determined. 36 -h incubation ofL-1251-T4 wvith GH1 cells. L-125I-T4, purified as previously described (1, 32) , was incubated with GH1 cells at 50 nM with and without a 500-foldl molar excess of nonradioactive L-T4. The flasks were then chilled to 40C, the meditum removed, and the cell monolayers were rinsed four times with 0.14 M NaCl at 4°C. Nuclear and extranuclear cells fractions were isolated as previously described (1, 6, 7). The samples were adjusted to 0.015 N NaOH -0.5 M NaCl, and 0.3 ml of the cellular material was applied to a 5-ml Sephadex G-25 (fine) column (Pharmacia Fine Chemicals, Inc., Div. Pharmacia Inc., Piscataway, N. J.) preequilibrated with the same buffer. The column was then eluted stepwise with 0.9-ml fractions of 0.1 N NaOH -5 mM NaCl. 100 ,ul of media was adjusted to 0.015 N NaOH -0.5 M NaCl and chromatographed in the same fashion. With this procedure (1, 34) methionine incorporation followed by immunoprecipitation with highly selective anti-growth hormone antibody (6) . D-T3 induced a half-maximal growth hormone response at 4 nM, and L-T4 induced a half-maximal response at 9 nM. Therefore, under the conditions in which the medium is supplemented with 10% hypothyroid calf serum, triac has 89.5%, D-T3 has 4%, and L-T4 has 2% of the activity of L-T3.
Relative affinity of hormonal analogues for the thyroid hormone nuclear receptor in serum-containing medium. An estimation ofthe relative affinity of L-T3, triac, D-T3, and L-T4 for the thyroid hormone nuclear receptor was performed with intact cells and medium that contained hypothyroid calf serum to allow for a relative comparison with the growth hormone doseresponse curves. Fig. 2 Dose-dependent depletion of the thyroid hormotne nuclear receptor by hormonal analogues. With GH, cells in medium that contained 10% hypothyroid calf serum, we previously reported that the concentration of L-T3 which results in half-maximal occupancy of the thyroid hormone nuclear receptor was 0.51 nM (6) . Based on this value and the relative inhibition data of Fig. 2 , the iodothyronine concentrations which would result in half-maximal occupancy of the nuclear receptor was calculated to be 0.57 nM for triac, 9.8 nM for D-T3, and 25 nM for L-T4. From the iodothyronine concentrations which result in half'-maximal induction of growth hormone synthesis in Fig. 1 , it is apparent that the growth hormone response curves are shifted leftward ofthe receptor occupancy curves by a factor of =2.5. In previous studies with L-T3 (6, 7) this shift in the growth hormone response curve from the receptor occupancy curve appeared to result from a dose-dependent hormone-mediated reduiction in nuclear receptor levels, and the L-T3 concentration which resulted in one-half of the maximal level of receptor depletion was 0.17 nM. Therefore, the results of Figs. 1 and 2 would suggest that triac, D-T3, and L-T4, would be expected to elicit a dose-dependent reduction in 1232
H. H. Samuels, F. Stanley, andJ. Casanova thyroid hormone nuclear receptor levels. Fig. 3 illustrates the results ofa study in which this was examined. The cells were initially incubated with the concentrations of iodothyronine indicated in Fig. 3 for 24 h, followed by an incubation with 5 nM L-[125I]T3 for 3 h. Total nuclear receptor levels were calculated using Eq. 2 described in Methods and the affinity of each compound for the receptor relative to L-T3 derived from Fig. 2 . Fig. 3 indicates that each compound elicits a 40% decrease in total nuclear receptor levels, and the dose-dependent reduction of receptor parallels the affinities of the analogues for the receptor. One-half of the maximal reduction in nuclear receptor levels occurred at 0. After the incubation the medium was saved, and the nuclear and extranuclear fractions of the cells were isolated (1, 6, 7) . The 125iodo-thyronine was dissociated from binding protein with 0.015 N NaOH -0.5 M NaCl, and the samples were chromatographed on Sephadex G-25 (fine) columns to separate iodide, L-T3, and L-T4, as previously described (34) . The concentration of L-T4 used in this study (50 nM) induced a maximal growth hormone response ( Fig. 1) and elicited a reduction in thyroid hormone nuclear receptor levels to 90% of the final steady-state value (Fig. 3) . With this concentration of L-T4, the occupancy of the nuclear receptor by L-T3 represents a maximum of 10% of the total receptor binding sites (Fig. 4) . This degree of occupancy of the receptor by L-T3 elicits a growth hormone response and receptor depletion which are <20% of the values obtained with full receptor occupancy by L-T3 (6, 7). Therefore, the major biologic effects of L-T4 in GH, cells on receptor depletion and growth hormone reduction appear to be mediated by L-T4 and not L-T3 formed as a result of conversion.
Quantitation of media-free L-T3 and L-T4 and comparison to serum-free studies. To make a direct comparison between the relative affinity for the receptor, the growth hormone response, and receptor depletion, the cellular responses were studied with Ham's F-10 medium supplemented with 10% hypothyroid calf serum. Although this allows a valid relative comparison between iodothyronine analogue binding characteristics and growth hormone induction and regulation of the receptor, it does not allow a direct measurement of the intrinsic differences in biological activity as a result of inherent differences in the serum binding of the analogues. In an earlier study with intact GH, cells and serum-free Ham's F-10 media, the Kd for nuclear binding was determined to be 0.029 nM for L-T3 and 0.26 nM for L-T4 (1). This 9.7-fold difference between L-T4 and L-T3 differs from the -50-fold difference in the L-T4 response determined in Figs. 1-3 relative to that of L-T3. Therefore, the free L-T3 and L-T4 fractions were quantitated in Ham's F-10 medium which contained 10% hypothyroid calf serum to allow for direct comparison with the affinities determined with intactcell studies with serum-free media. Between 0.01-5 nM L-T3 and 0.1-50 nM L-T4 the percentage of total media hormone concentrations which was in the free fraction was estimated to be 5% for L-T3 and 1% for L-T4. With these values and the demonstration that 0.51 nM L-T3 in serum-containing medium occupies 50% of the receptor binding sites (6) , it is possible to compare the L-T3 and L-T4 results in this study with earlier serum-free experiments (1). The estimated free hormone concentration which results in half-maximal occupancy of the thyroid hormone receptor was calculated to be 0.026 nM for L-T3 and 0.26 nM for L-T4. These results are essentially identical, therefore, to the Kd values determined for L-T3 and L-T4 binding to nuclear receptor in intact cells using serum-free conditions (1) .
Relative receptor affinity of thyroid analogues with intact cells in serum-free medium and with isolated GH, cell nuclei in vitro. Studies with isolated liver nuclei by Koemer et al. (21) and DeGroot and Torresani (23) have demonstrated that triac has a 164 (21) to 400% (23) greater affinity than L-T3, whereas the relative affinity of D-T3 was equal to (23) or 60% (21) of that of L-T3. These results differ significantly from the relative affinity determined in intact cells with 10% hypothyroid calf serum medium in which triac had an affinity which was slightly less then L-T3, and D-T3 had only 5.8% of the affinity as compared with L-T3. These differences may reflect a greater avidity of serum-binding proteins for these analogues, intrinsic differences in cell entry, or differences in the nuclear receptor derived from GH, cells and liver.
To explore these possibilities, we compared the relative affinity of the iodothyronine analogues for nuclear receptors in intact cells in serum-free conditions (Fig.   5 ), and in isolated GH, cell nuclei in vitro (Fig. 6) .
In intact cells, triac had 306%, D-T3 had 9.6%, and L-T4 had 8% of the affinity relative to L-T3. The apparent increase in relative affinities for triac and L-T4 are consistent with the greater serum binding of triac and L-T4 (25) as compared with L-T3. With serum-free conditions, however, the D-T3 relative affinity in intact cells is only slightly greater then with serum-containing medium (Fig. 2) . Fig. 6 illustrates the relative affinities of the analogues for the nuclear receptor using isolated GH, nuclei in vitro. In this study triac had 400%, D-T3 had 53%, and L-T4 had 10% ofthe affinity for the receptor as compared with L-T3.
These results with isolated GH, cell nuclei are similar to those previously reported with isolated rat liver nuclei (21, 23) . Furthermore, the affinity of triac and L-T4 as compared with L-T3 are also almost identical with isolated nuclei to that determined in the serumfree intact-cell study indicating no apparent differences in cell permeability of L-T3, triac, and L-T4. In contrast, the relative affinity of D-T3 is 5. Influence of L-T3 on growth hormone induction and thyroid hormone receptor depletion in dispersed rat anterior pituitary cells. In the rat, thyroidectomy markedly lowers the pituitary and serum growth hormone content, and this is rapidly restored by thyroid hormone administration (9) (10) (11) (12) . The onset and timecourse of growth hormone accumulation in GH, cells (36) and in the rat pituitary in vivo (12) are essentially identical, which suggests that thyroid hormone induces this response by the same mechanism in GH, cells and the pituitary somatotroph. It has been reported (13) that thyroid hormone does not induce an increase in growth hormone production in dispersed anterior pituitary cells. The medium used in these studies, however, was supplemented with fetal calf serum which contains high endogenous thyroid hormone levels. Therefore, with medium that contained hypothyroid calf serum, we examined whether L-T3 induces growth hormone production in dispersed rat pituitary cells, and we also studied whether L-T3 elicits a reduction in pituitary nuclear receptor levels. Table I 50,000 GH, cells or dispersed rat pituitary cells were inoculated into 2-cm2 multiwell culture plates and were treated with Ham's F-10 media which contained 10% hypothyroid calf serum as described in Methods. The L-T3 concentration was 5 nM, and the growth hormone production rates reflect the growth hormone which accumulated in the medium between 24 and 48 h of incubation. The intracellular growth hormone levels reflect that at 48 h of incubation. Cell protein was 23 ug±+10% in the rat pituitary cell cultures and 30 ug±10% in the GH1 cell cultures.
The growth hormone production responses reflect the mean of triplicate cultures with <±8% variation. * In a separate study at 48 h, growth hormone synthetic rates were determined by a 15-min incubation with L-[35S]methionine (50 uCi/ml) followed by selective immunoprecipitation of the intracellular radiolabeled growth hormone as previously described for GH1 cells (5) . Subsequently, similar values for L-T3 were reported in different cell culture systems. Gershengorn (38) recently reported that 0.2 nM L-T3 resulted in half-maximal inhibition of thyroid-stimulating hormone produc- (6, 7) . We have presented evidence that the nuelear receptor exists as two functional populations: one which represents 40-50% of total receptor, is depletable by L-T3, and is involved in the regulation ofgrowth hormone response; and a nondepletable fraction which is not involved in the control of growth hormone synthesis buit may have other regulatory functions (7) . The main implications of this observation is that a partial reduction of the total receptor (depletable plus nondepletable) would result in a significant reduction in the magniitude of the growth hormone response (7) . Both putative populations of receptor had identical affinities for L-T3, and the initial rate of disappearance of the depletable receptor population was a direct f'unctioni of the occupaincy by L-T3 and new steady-state levels of receptor were achieved within 24 h of incubation (6, 7) . In this study we demonstrated that both putative populations of receptor also have identical affinities for each analogue examined (Fig. 2) , and modulation of nuclear receptor levels also occurs with each analogue as a direct function of the iodlothvronine fractional occupancy of the receptor bindling site (Fig. 3) .
Although studies with serumil-conitaininig mediumln demonstrate an excellent relationship between the relative association of iodothyronine with the receptor and the growth hormone response, the relative affinities as compared with L-T3 differ markedly from that reported with isolated hepatic nuclei in vitro (21) (22) (23) . These differences may reflect diff'erential serum binding of iodothyronine analogues, intrinsic differences in cell entry, or an intrinsic dlifference in the nuclear receptor derived from GH1 cells and rat liver. Based on the estimation of the free L-T3 anid L-T4 levels in serum-containing medium, the discrepancy for L-T4 appears to reflect enhanced serum tbinding of'L-T4 relative to L-T3.
To further examine these questions we compared the relative affinity of iodothyronine analogues with nuclear receptors in intact GH, cells, using serum-free conditions, and in isolated GH, cell nuclei in vitro. The results obtained with isolated GH, cell nuclei are similar to that previously reported with isolated rat liver nuclei (21, 23) . Triac had 400%, D-T3 had 53%, and L-T4 had 10% ofthe affinity for the receptor as compared with L-T3. The affinity of triac and L-T4 relative to L-T3 in intact cells was essentially identical with that observed in isolated GH, cell nuclei. In contrast, the relative affinity of D-T3 is 5.5-fold lower in intact cells with serum-free conditions as compared with isolated GH, cell or liver nuclei, which implies a relative decrease in cell entry of D-T3 as compared with the other hormonal analogues. This suggests that differences in iodothyronine cell entry may in part explain a discrepancy between the relative receptor affinity determined with isolated hepatic nuclei in vitro and the biologic response elicited after in vivo injection. Furthermore, if selective differences in tissue permeability to iodothyronines occurred, certain analogues may be more effective in eliciting thyroid hormone effects in certain tissues after in vivo injection. This is suggested by the observations of Oppenheimer et al. (40) (41) ; have less nuclear receptor than somatotrophic cells (38) ; and, as estimated by immunoperoxidase staining, grow poorly under culture conditions (44) . If thyroid hormone controlled the level of thyroid hormone nuclear receptors in the somatotroph in vivo, extrapolation ofour observations on hormone-mediated reduction of the receptor and the growth hormone response in GH, cells (6, 7) may allow prediction of the growth hormone response in different thyroidal states in vivo. In the hypothyroid rat thyroid hormone nuclear receptor levels would be high, and the somatotroph would be expected to show a marked increase in the growth hormone response to a single injection ofthyroid hormone. This has been observed by Hervas et al. (12) . In addition, with chronic thyroid hormone administration in euthyroid rats sufficient to induce thyrotoxicosis, reduction of the receptor would be expected to lower the magnitude ofthe growth hormone response relative to that of the euthyroid state.
Only a limited number of studies, however, have examined the effect of chronic thyroid hormone administration on the growth hormone response in the rat (9, 45) . In early studies relating thyroid function and the growth hormone response, Solomon and Greep (9) estimated the growth hormone content of the rat pituitary to be 26 ,ug/mg pituitary±36.1% in the thyroidectomized rat, and 170 pLg/mg pituitary ±36% in the euthyroid rat. After thyroid hormone administration sufficient to induce thyrotoxicosis, the growth hormone content of the pituitary decreased to 75.2 ,ug/mg pituitary ±35.5%. Recently, Coulombe et al. (45) reported that daily injection of thryoid hormone in euthyroid rats, sufficient to produce thyrotoxicosis, decreased the pituitary growth hormone content as compared with euthyroid controls. Therefore, the growth hormone response parameters in the rat as a function ofthe thyroidal state approximates a bell-shaped curve with a reduction in pituitary growth hormone content both in the hypothyroid and thyrotoxic rate.
Studies on the influence of thyroid hormone on the physiology of growth hormone in man tend to parallel the observations in the rat although the studies demonstrate some variability in the response (46, 47) . In a series ofreported studies, between 40 and 80% of hypothyroid patients demonstrated a blunted growth hormone response to insulin-induced hypoglycemia, and in the majority ofthese patients the response normalized after thyroid hormone administration and restoration of the euthyroid state (46) (47) (48) . In thyrotoxicosis, insulin-induced hypoglycemia tends to result in subnormal growth hormone responses as compared with euthyroid controls, and this is restored to normal levels after restoration of euthyroidism (49, 50) . Finkelstein et al. (50) quantitated the growth hormone plasma halflife and 24-h secretory rates in hyperthyroid patients and euthyroid controls. The plasma half-life was unchanged in hyperthyroidism but the 24-h secretory rates were reduced _43%, and this was restored to normal after restoration of the euthyroid state. Therefore, although studies in man do not allow estimation ofpituitary growth hormone content, the general pattern of growth hormone response as a function of thyroidal state is qualitatively similar to that determined experimentally in the rat.
Modulation of the thyroid hormone nuclear receptor level in the somatotroph provides a plausable explanation for the influence of the thyroidal state on the growth hormone response in vivo. By this mechanism, alterations in receptor levels would be associated with changes in the production rates and steady-state levels of growth hormone mRNA. Variations in the growth hormone response in different thyroidal states, however, may be secondary to changes in the turnover or degradation ofpituitary growth hormone or growth hormone mRNA. Resolution ofthe detailed aspects ofthese parameters should provide an understanding of the influence of the thyroidal state on the growth hormone response.
